| (Values in U.S. Thousands) | Mar, 2021 | Dec, 2020 | Sep, 2020 | Jun, 2020 | Mar, 2020 |
| Sales | 0 | 60 | 40 | 700 | 780 |
| Sales Growth | -100.00% | +50.00% | -94.29% | -10.26% | -1.27% |
| Net Income | -4,170 | -1,320 | -1,560 | -4,190 | -5,260 |
| Net Income Growth | -215.91% | +15.38% | +62.77% | +20.34% | -7.13% |
Obalon Therapeutics Inc (OBLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Obalon Therapeutics, Inc. is a medical device company. It focused on developing and commercializing medical devices to treat obese and overweight. The company's product consists of Obalon balloon system, the first swallowable, gas-filled intragastric balloon designed to provide progressive and sustained weight loss in obese patients. Obalon Therapeutics, Inc. is based in San Diego, California.